EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Alpha‐lipoic acid as a preventive measure in radiation‐induced oral mucositis in head and neck cancer patients: A randomized controlled study

Beshoy Anwar Rizkalla, Mohamed Reda Kelany iD, Nagwa Ali Sabri iD, May Ahmed Shawki iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70497 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Beshoy Anwar Rizkalla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Thioctic Acid, Stomatitis, Head and Neck Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Alpha‐lipoic acid (ALA), a potent antioxidant, anti‐inflammatory and cytoprotective drug, has revealed potential efficacy in pre‐clinical studies in reducing radiation induced oral mucositis (RIOM). This study aims to evaluate the protective effects of ALA on RIOM.

Methods

In this randomized controlled study, 70 head and neck cancer (HNC) patients receiving definitive radiotherapy were assigned to receive either oral ALA (600 mg twice daily) or placebo tablets throughout the radiotherapy period. The primary outcome was the assessment of the incidence and severity of RIOM using the Radiotherapy Oncology Group (RTOG) grading system. Secondary outcomes were the onset and duration of severe RIOM (Grades 3 and 4), quality of life (QOL), and serum total antioxidant capacity (TAC) and C‐reactive protein (CRP).

Results

The incidence of severe RIOM was 16.7% with the use of ALA, while in the control group it was 41.3% ( p value = 0.036). Moreover, ALA significantly delayed the occurrence of severe RIOM ( p value = 0.033) and resulted in significantly shorter healing time ( p value = 0.042). At the end of the study, ALA resulted in a mean percent change in QOL score from baseline of 43.33, which was non‐significantly different from the control group with a mean of 44.84. ALA significantly improved TAC levels but had no effect on CRP. The use of ALA was safe and tolerable.

Conclusion

ALA showed a significant reduction in the severity and delayed the onset of RIOM with a high safety profile through its potent antioxidant effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thioctic AcidStomatitisHead and Neck NeoplasmsRadiation InjuriesAntioxidantsHumansMaleFemaleQuality of LifeMiddle AgedAgedAdultDouble-Blind MethodC-Reactive ProteinSeverity of Illness Index

Stichwörter der Autor:innen

alpha‐lipoic acidhead and neck canceroral mucositisquality of liferadiotherapytotal antioxidant capacity

Substanzen

Thioctic AcidAntioxidantsC-Reactive Protein

Autor:innen und Institutionen

  • Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
  • Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Mohamed Reda Kelany, Nagwa Ali Sabri, May Ahmed Shawki

Zitieren

APA

Rizkalla, B. A., Kelany, M. R., Sabri, N. A., & Shawki, M. A. (2026). Alpha‐lipoic acid as a preventive measure in radiation‐induced oral mucositis in head and neck cancer patients: A randomized controlled study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70497

Vancouver

Rizkalla BA, Kelany MR, Sabri NA, Shawki MA. Alpha‐lipoic acid as a preventive measure in radiation‐induced oral mucositis in head and neck cancer patients: A randomized controlled study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70497

BibTeX
@article{Rizkalla2026,
  author = {Rizkalla, Beshoy Anwar and Kelany, Mohamed Reda and Sabri, Nagwa Ali and Shawki, May Ahmed},
  title = {Alpha‐lipoic acid as a preventive measure in radiation‐induced oral mucositis in head and neck cancer patients: A randomized controlled study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70497}
}
Kostenlos starten →